Collective data from major clinical trials have shown that treatment with a DPP-4i improves glycemic control by increasing insulin secretion from islet cells, lowering levels of HbA1c, reducing adipocyte size, and suppressing inflammation [47,48,49,50,51]
There is a quieter benefit to spreading the work across two compounds
Erratum in: J Cell Mol Med
CJC-1295 & Ipamorelin Blend Dosing: GH Release, Ratio and Timing Dr
doi:10.1007/s11011-013-9435-x, PMID: 24557875 Sadowska AM, Manuel-Y-Keenoy B, De Backer WA (2007) Antioxidant and anti-inflammatory efficacy of NAC in the treatment of COPD: discordant in vitro and in vivo dose-effects: a review